Ryan Specialty Holdings, Inc. (NYSE:RYAN) Stock Position Lowered by Mawer Investment Management Ltd.

Mawer Investment Management Ltd. reduced its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 4.3% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 628,439 shares of the company's stock after selling 28,500 shares during the quarter. Mawer Investment Management Ltd. owned approximately 0.24% of Ryan Specialty worth $41,722,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in RYAN. Principal Financial Group Inc. raised its holdings in Ryan Specialty by 148.9% in the third quarter. Principal Financial Group Inc. now owns 851,704 shares of the company's stock worth $56,545,000 after purchasing an additional 509,548 shares in the last quarter. Bessemer Group Inc. lifted its position in Ryan Specialty by 33.9% in the 1st quarter. Bessemer Group Inc. now owns 1,925,864 shares of the company's stock valued at $106,886,000 after acquiring an additional 488,067 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Ryan Specialty by 132.2% in the 2nd quarter. Bank of New York Mellon Corp now owns 836,209 shares of the company's stock worth $48,425,000 after purchasing an additional 476,126 shares in the last quarter. 2Xideas AG purchased a new position in shares of Ryan Specialty in the first quarter worth $19,765,000. Finally, Driehaus Capital Management LLC purchased a new stake in shares of Ryan Specialty during the second quarter valued at $16,313,000. Hedge funds and other institutional investors own 84.82% of the company's stock.

Ryan Specialty Trading Down 0.4 %

Shares of RYAN traded down $0.26 during midday trading on Monday, hitting $70.68. 620,600 shares of the stock were exchanged, compared to its average volume of 871,882. The stock has a fifty day simple moving average of $68.28 and a 200 day simple moving average of $61.97. Ryan Specialty Holdings, Inc. has a 52-week low of $41.49 and a 52-week high of $73.10. The firm has a market cap of $18.51 billion, a P/E ratio of 91.56, a P/E/G ratio of 1.61 and a beta of 0.62. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The company had revenue of $604.69 million during the quarter, compared to the consensus estimate of $602.04 million. During the same period in the previous year, the business earned $0.32 EPS. Ryan Specialty's revenue for the quarter was up 20.5% on a year-over-year basis. On average, research analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.8 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th will be issued a $0.11 dividend. The ex-dividend date is Tuesday, November 12th. This represents a $0.44 annualized dividend and a dividend yield of 0.62%. Ryan Specialty's dividend payout ratio is currently 57.14%.

Insiders Place Their Bets

In other news, EVP Mark Stephen Katz sold 14,790 shares of the stock in a transaction on Friday, November 8th. The shares were sold at an average price of $71.39, for a total value of $1,055,858.10. Following the completion of the sale, the executive vice president now owns 12,386 shares of the company's stock, valued at $884,236.54. This represents a 54.42 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of the stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $65.15, for a total value of $2,280,250.00. Following the completion of the sale, the director now owns 9,115 shares of the company's stock, valued at approximately $593,842.25. This trade represents a 79.34 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 59,193 shares of company stock worth $3,944,343. Corporate insiders own 11.10% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have weighed in on the company. Wells Fargo & Company increased their target price on Ryan Specialty from $63.00 to $70.00 and gave the company an "equal weight" rating in a report on Thursday, October 10th. Bank of America raised their price objective on shares of Ryan Specialty from $75.00 to $84.00 and gave the stock a "buy" rating in a report on Thursday, October 10th. The Goldman Sachs Group upped their target price on shares of Ryan Specialty from $64.00 to $72.00 and gave the company a "neutral" rating in a report on Wednesday, October 9th. UBS Group boosted their price objective on shares of Ryan Specialty from $67.00 to $76.00 and gave the company a "buy" rating in a research report on Tuesday, August 13th. Finally, JPMorgan Chase & Co. raised their target price on Ryan Specialty from $54.00 to $56.00 and gave the stock an "underweight" rating in a report on Friday, August 2nd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the company's stock. According to MarketBeat, Ryan Specialty has an average rating of "Hold" and an average price target of $70.33.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.